403 related articles for article (PubMed ID: 23857124)
21. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Chang KL; New LS; Mal M; Goh CW; Aw CC; Browne ER; Chan EC
J Proteome Res; 2011 Apr; 10(4):2079-87. PubMed ID: 21355552
[TBL] [Abstract][Full Text] [Related]
22. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
23. Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method.
Xu X; Cheng S; Ding C; Lv Z; Chen D; Wu J; Zheng S
Mol Med Rep; 2015 Mar; 11(3):2191-8. PubMed ID: 25405977
[TBL] [Abstract][Full Text] [Related]
24. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
[TBL] [Abstract][Full Text] [Related]
25. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
26. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
27. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
Teul J; Rupérez FJ; Garcia A; Vaysse J; Balayssac S; Gilard V; Malet-Martino M; Martin-Ventura JL; Blanco-Colio LM; Tuñón J; Egido J; Barbas C
J Proteome Res; 2009 Dec; 8(12):5580-9. PubMed ID: 19813770
[TBL] [Abstract][Full Text] [Related]
28. Effects of glaucocalyxin A on human liver cancer cells as revealed by GC/MS- and LC/MS-based metabolic profiling.
Liu Y; Lu S; Zhao L; Dong X; Zhu Z; Jin Y; Chen H; Lu F; Hong Z; Chai Y
Anal Bioanal Chem; 2018 May; 410(14):3325-3335. PubMed ID: 29651531
[TBL] [Abstract][Full Text] [Related]
29. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
30. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
31. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
[TBL] [Abstract][Full Text] [Related]
32. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry.
Savolainen OI; Sandberg AS; Ross AB
J Proteome Res; 2016 Jan; 15(1):259-65. PubMed ID: 26615962
[TBL] [Abstract][Full Text] [Related]
33. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
34. A GC-MS metabolic profiling study of plasma samples from mice on low- and high-fat diets.
Spagou K; Theodoridis G; Wilson I; Raikos N; Greaves P; Edwards R; Nolan B; Klapa MI
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1467-75. PubMed ID: 21388899
[TBL] [Abstract][Full Text] [Related]
35. Metabolomic Profiling of Plasma Samples from Women with Recurrent Spontaneous Abortion.
Li X; Yin M; Gu J; Hou Y; Tian F; Sun F
Med Sci Monit; 2018 Jun; 24():4038-4045. PubMed ID: 29898462
[TBL] [Abstract][Full Text] [Related]
36. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
37. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
38. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
39. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
